アブストラクト
| Title | Relation between glycemia level and common carotid artery intima-media thickness in females |
|---|---|
| Subtitle | Original Article |
| Authors | Nikola Baric1), Sanja Baric Santro2) |
| Authors (kana) | |
| Organization | 1)Private General Practice Office, 2)Department for Pediatry, Istrian Health Centers-Branch Unit Dr. Lino Persic Labin |
| Journal | Glycative Stress Research |
| Volume | 3 |
| Number | 1 |
| Page | 23-37 |
| Year/Month | 2016 / |
| Article | Original article |
| Publisher | Glycative Stress Research |
| Abstract |
[Abstract] Objective: The onset and course of carotid atherosclerosis are strongly influenced by interconnected effects of well-known risk factors, each of which influence this disease. Using standard...
続きをご覧いただくにはログインが必要です。 |
| Practice | General medicine |
| Keywords | fasting glycemia level, glycative stress, common carotid artery intima-media thickness, carotid atherosclerosis |
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: Molecular mechanisms. Cardiovasc Diabetol. 2002; 1: 1.
- 2) Esposito K, Ciugliano D, Nappo F, et al. Regression of carotid atheroscle-rosos by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation. 2004; 110: 214-219.
- 3) Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clinical Diabetes. 2003; 21: 186-187.
- 4) Nielson C, Fleming RM. Blood glucose and cerebrovascular disease in nondiabetic patients. Angiology. 2007; 58: 625-629.
- 5) Baric N, Materljan E, Baric-Santro S. Korelacija izmedu zivotne dobi i debljine intima-medija. kompleksa zajednicke karotidne arterije kao mark-era aterogeneze. U: Mazzi B. ur.Zbornik-Sedmi kongres HDOD-HLZ.. Rovinj 2007; str. 111-28.
残りの38件を表示する
- 6) Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation. 2006; 114: 597-605.
- 7) Nagai R. Accumulation of advanced glycation end products in age-dependent disorders. Med Hypotheses Res. 2004; 1: 161-170.
- 8) Alikhani M, MacLellan CM, Raptis M, et al. Advanced glycation end pro-ducts induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Am J Physiol Cell Physiol. 2007; 292: C850-856.
- 9) Nagai R, Matsumoto K, Ling X, et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for macrophage scavenger receptor. Diabetes. 2000; 49: 1714-1723.
- 10) Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med. 1998; 218: 23-37.
- 11) Nagai R, Unno Y, Hayashi MC, et al. Peroxynitrite induces formation of Nε-(carboxymethyl)-lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: Novel pathways for protein modification by peroxynitrite. Diabetes. 2002; 51: 2833-2839.
- 12) Hayashi CM, Nagai R, Miyazaki K, et al. Conversion of Amadori products of the Maillard reaction to Nε-(carboxymethyl) lysine by short-term heating: Possible detection of artifacts by immunohistochemistry. Lab Invest. 2002; 82: 795-808.
- 13) Baric N, Materljan E, Juretic M, et al. Utjecaj procesa starenja na odnos sirina intima-medija/unutrasnji promjer u zajednickoj karotidnoj arteriji. U: Mazzi B. ur. Zbornik-Osmi kongres HDOD-HLZ. Rovinj 2008; str. 77-94.
- 14) Wagenknecht LE, D'Agostino R Jr, Savage PJ, et al. Duration of diabetes and carotid wall thickness: The insulin resistence atherosclerosis study (IRAS). Stroke. 1997; 28: 999-1005.
- 15) Hegazi RA, Sutton-Tyrreell K, Evans RW, et al. Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes. Obes Res. 2003; 11: 1597-1605.
- 16) Lee EJ, Kim HJ, Bae JM, et al. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. AJNR. 2007; 28: 916-919.
- 17) Ciccone MM, De Pergola G, Porcelli MT, et al. Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: An adiposity and autoimmune linkage? BMC Cardiovasc Disord. 2010; 10: 22.
- 18) Selvin E, Coresh J, Golden SH, et al. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: The atherosclerosis risk in communities study. Diabetes Care. 2005; 28: 1965-1973.
- 19) Kim CS, Park SY, Yu SH, et al. Is A1C variability an independent predictor for the progression of atherosclerosis in type 2 diabetic patients? Korean Diabetes J. 2010; 34: 174-181.
- 20) Pannacciulli N, De Pergola G, Ciccone M, et al. Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care. 2003; 26: 1230-1234.
- 21) Kozakova M, Palombo C, Morizzo C, et al. Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population. Eur Heart J. 2010; 31: 1511-1519.
- 22) Kozakova M, Natali A, Dekker J, et al. Insulin sensitivity and carotid intima-media thickness: Relationship between insulin sensitivity and cardiovascular risk study. Arterioscler Thromb Vasc Biol. 2013; 33: 1409-1417.
- 23) Semba RD, Beck J, Sun K, et al. Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The Baltimore Longitudinal Study of Aging. J Nutr Health Aging. 2010; 14: 507-513.
- 24) Teichert T, Hellwig A, Pessler A, et al. Association between advanced glycation end products and impaired fasting glucose: Results from the SALIA Study. PloS One. 2015; 10(5): e0128293.
- 25) Node K, Inoue T. Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol. 2009; 8: 23.
- 26) Kowall B, Ebert N, Then C, et al. Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: The KORA F4 study. PloS One. 2012; 7(12): e52590.
- 27) Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000; 49: 1939-1945.
- 28) Baumann M, Richart T, Sullinger D, et al. Association between carotid diameter and advanced glycation end product Nε-carboxymethyllysine (CML). Cardiovasc Diabetol. 2009; 8: 45.
- 29) Bakris GL, Bank AJ, Kass DA, et al. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens. 2004; 17: 23S-30S.
- 30) Asif M, Egan J, Vasan S, et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA. 2000; 97: 2809-2813.
- 31) Liu J, Masurekar MR, Vatner DE, et al. Glycation endproduct cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am J Physiol Heart Circ Physiol. 2003; 285: H2587-H2591.
- 32) Vaitkevicius PV, Lane M, Spurgeon H, et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci USA. 2001; 98: 1171-1175.
- 33) Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001; 56: 1-22.
- 34) Demarin V, Podobnik SS, Storga-Tomic D, et al. Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: A randomized, double-blind study. Drugs Exp Clin Res. 2004; 30: 27-33.
- 35) Ziemen SJ, Kass DA. Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail. 2004; 10: 144-151.
- 36) Semba RD, Najjar SS, Sun K, et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens. 2009; 22: 74-79.
- 37) He Z, King GL. Protein kinase Cβ isoform inhibitors: A new treatment for diabetic cardiovascular diseases. Circulation. 2004; 110: 7-9.
- 38) Inoguchi T, Sonta T, Tsubouchi H, et al. Protein kinase C-dependent in-crease in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003; 14: S227-S232.
- 39) Inoguchi T, Nawata H. NAD(P)H oxidase activation: A potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr Drug Targets. 2005; 6: 495-501.
- 40) Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on complications. Circ Res. 2010; 106: 1319-1331.
- 41) Uribarri J, Woodruff S, Goodman S, et al. Advanced Glycation end products in foods and a practical guide to their reduction in diet. J Am Diet Assoc. 2010; 110: 911-916.
- 42) Baric N. Role of advanced glycation and products in Alzheimer's disease. Glycative Stress Research. 2014; 1: 68-83.
- 43) Wang Y, Yu H, Shi X, et al. Structural mechanism of ring-opening reaction of glucose by human serum albumin. J Biol Chem. 2013; 288: 15980-15987.
